Novo Nordisk to add 615 jobs (USA)

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
The number of diabetics in America is growing.

The number of unemployed pharmaceutical workers seems to be doing the same.

That combination is bad, unless you are Novo Nordisk.

A relatively small Danish-based drug company with a U.S. home in Princeton, Novo Nordisk is in a sweet spot in the pharmaceutical landscape because the core of its business is diabetes. With 40 straight quarters of double-digit growth, the company said Friday it plans a 15 percent increase to its U.S. workforce, meaning about 615 more jobs, through the end of this year.

?A lot of people are not working in our industry right now,? said Andy Ajello, corporate vice president for diabetes sales. ?But we?re thriving and able to recruit the best.?

http://www.philly.com/philly/business/149304105.html
 
Status
Not open for further replies.
Back
Top